Hearing in individuals enrolled for drug-resistant tuberculosis treatment: a retrospective study from a South Indian city

References

• World Health Organization. Global tuberculosis report 2018. Geneva: World Health Organization; 2018. Available from: https://apps.who.int/iris/handle/10665/274453
   Google Scholar
• Pontali E, Matteelli A, Migliori GB. Drug-resistant tuberculosis. Curr Opin Pulm Med. 2013;19(3):266–272.
   PubMed Web of Science ®Google Scholar
• Yee D, Valiquette C, Pelletier M, et al. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med. 2003;167(11):1472–1477.
   PubMed Web of Science ®Google Scholar
• Zhang HQ, Xi XE, Wang YL, et al. Side effects of tuberculosis treatment with fixed-dose combinations. J Biol Regul Homeost Agents. 2015;29(2):379–388.
   PubMed Web of Science ®Google Scholar
• Ramachandran G, Swaminathan S. Safety and tolerability profile of second-line anti-tuberculosis medications. Drug Saf. 2015;38(3):253–269.
   PubMed Web of Science ®Google Scholar
• Seddon JA, Godfrey-Faussett P, Jacobs K, et al. Hearing loss in patients on treatment for drug-resistant tuberculosis. Eur Respir J. 2012;40(5):1277–1286.
   PubMed Web of Science ®Google Scholar
• Vasconcelos K. d, Lima M. d M d, Frota S, et al. Audiometric evaluation of patients treated for pulmonary tuberculosis. J Bras Pneumol. 2012;38(1):81–87.
   PubMed Web of Science ®Google Scholar
• Törün T, Güngör G, Ozmen I, et al. Side effects associated with the treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2005;9(12):1373–1377.
   PubMed Web of Science ®Google Scholar
• Vasconcelos K. d, Frota SMMC, Ruffino-Netto A, et al. The importance of audiometric monitoring in patients with multidrug-resistant tuberculosis. Rev Soc Bras Med Trop. 2017;50(5):646–651.
   PubMed Web of Science ®Google Scholar
• Yang TW, Park HO, Jang HN, et al. Side effects associated with the treatment of multidrug-resistant tuberculosis at a tuberculosis referral hospital in South Korea: a retrospective study. Medicine (Baltimore). 2017;96(28):e7482.
   PubMed Web of Science ®Google Scholar
• Tag El Din MA, El Maraghy AA, Abdel Hay AHR. Adverse reactions among patients being treated for multi-drug resistant tuberculosis at Abbassia Chest Hospital. Egypt J Chest Dis Tuberc. 2015;64(4):939–952.
   Web of Science ®Google Scholar
• Sturdy A, Goodman A, José RJ, et al. Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice. J Antimicrob Chemother. 2011;66(8):1815–1820.
   PubMed Web of Science ®Google Scholar
• Harbert F, Riordan D. Tuberculosis of the middle ear. Laryngoscope. 1964;74(2):198–204.
   PubMedGoogle Scholar
• Awan MS, Salahuddin I. Tuberculous otitis media: two case reports and literature review. Ear Nose Throat J. 2002;81(11):792–794.
   PubMedGoogle Scholar
• Wallner LJ. Tuberculous otitis media. Laryngoscope. 1953;63(11):1058–1077.
   PubMed Web of Science ®Google Scholar
• Sogebi OA, Fadeyi MO, Adefuye BO, et al. Hearing thresholds in patients with drug-resistant tuberculosis: baseline audiogram configurations and associations. J Bras Pneumol. 2017;43(3):195–201.
   PubMed Web of Science ®Google Scholar
• Carhart R, Jerger J. Preferred method for clinical determination of pure-tone thresholds. J Speech Hear Disord. 1959;24(4):330–345.
   Google Scholar
• Goodman A. Reference zero levels for pure tone audiometer. Am Speech Hear Assoc. 1965;7:262–263.
   Google Scholar
• Gülbay BE, Gürkan OU, Yildiz OA, et al. Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis. Respir Med. 2006;100(10):1834–1842.
   PubMed Web of Science ®Google Scholar
• Warpe B, Poflee S, Pande N, et al. Tuberculous neuritis: a rare sequel of a common disease. Indian J Pathol Microbiol. 2014;57(1):69–71.
   PubMed Web of Science ®Google Scholar
• Akkara SA, Singhania A, Akkara AG, et al. A study of manifestations of extrapulmonary tuberculosis in the ENT Region. Indian J Otolaryngol Head Neck Surg. 2014;66(1):46–50.
   PubMedGoogle Scholar
• Weiner GM, O'Connell JE, Pahor AL. The role of surgery in tuberculous mastoiditis: appropriate chemotherapy is not always enough. J Laryngol Otol. 1997;111(8):752–753.
   PubMed Web of Science ®Google Scholar
• Gatell JM, Ferran F, Araujo V, et al. Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides. Antimicrob Agents Chemother. 1987;31(9):1383–1387.
   PubMed Web of Science ®Google Scholar
• Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7):e152.
   PubMed Web of Science ®Google Scholar
• Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9(12):737–746.
   PubMed Web of Science ®Google Scholar
• Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9(1):81.
   PubMed Web of Science ®Google Scholar
• Heysell SK, Ahmed S, Rahman MT, et al. Hearing loss with kanamycin treatment for multidrug-resistant tuberculosis in Bangladesh. Eur Respir J. 2018;51(3):1701778.
   PubMed Web of Science ®Google Scholar
• Pratap D, Rajeshwary A, Shastri U, et al. Does dyslipidemia worsen the hearing level in diabetics? J Otol. 2017;12(4):198–201.
   PubMedGoogle Scholar
• Kakarlapudi V, Sawyer R, Staecker H. The effect of diabetes on sensorineural hearing loss. Otol Neurotol. 2003;24(3):382–386.
   PubMed Web of Science ®Google Scholar
• Lin BM, Curhan SG, Wang M, et al. Hypertension, diuretic use, and risk of hearing loss. Am J Med. 2016;129(4):416–422.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Mishra A, Jagade M, et al. Effects of hypertension on hearing. Indian J Otolaryngol Head Neck Surg. 2013;65(Suppl 3):614–618.
   PubMedGoogle Scholar
• Sagwa E, Ruswa N, Musasa JP, et al. Adverse events during treatment of drug-resistant tuberculosis: a comparison between patients aith or without human immunodeficiency virus co-infection. Drug Saf. 2013;36(11):1087–1096.
   PubMed Web of Science ®Google Scholar
• Hong H, Budhathoki C, Farley JE. Increased risk of aminoglycoside-induced hearing loss in MDR-TB patients with HIV coinfection. Int J Tuberc Lung Dis. 2018;22(6):667–674.
   PubMed Web of Science ®Google Scholar
• Weinstein BE, Ventry IM. Audiometric correlates of the Hearing Handicap Inventory for the elderly. J Speech Hear Disord. 1983;48(4):379–384.
   PubMedGoogle Scholar
• Sindhusake D, Mitchell P, Smith W, et al. Validation of self-reported hearing loss. The Blue Mountains Hearing Study. Int J Epidemiol. 2001;30(6):1371–1378.
   PubMed Web of Science ®Google Scholar
• Chisolm TH, Johnson CE, Danhauer JL, et al. A systematic review of health-related quality of life and hearing aids: final report of the American Academy of Audiology task force on the health-related quality of life benefits of amplification in adults. J Am Acad Audiol. 2007;18(2):151–183.
   PubMed Web of Science ®Google Scholar
• Brown J, Capocci S, Smith C, et al. Health status and quality of life in tuberculosis. Int J Infect Dis. 2015;32:68–75.
   PubMed Web of Science ®Google Scholar